{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:08:14Z","timestamp":1777946894721,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pan.2025.11.012","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:30:14Z","timestamp":1763746214000},"page":"517-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reevaluating rifaximin prophylaxis in severe acute pancreatitis: A call for methodological refinement and microbiome-centric endpoints"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-2605","authenticated-orcid":false,"given":"Parth","family":"Aphale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5383-4226","authenticated-orcid":false,"given":"Himanshu","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7781-9987","authenticated-orcid":false,"given":"Shashank","family":"Dokania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2025.11.012_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.pan.2025.09.009","article-title":"Effect of oral rifaximin for prevention of infected pancreatic necrosis and mortality in severe acute pancreatitis: an open-label randomized controlled trial","volume":"25","author":"Kalia","year":"2025","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2025.11.012_bib2","first-page":"1193","article-title":"Early enteral nutrition and gut barrier protection in severe acute pancreatitis: a multicenter randomized trial","volume":"166","author":"Wu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2025.11.012_bib3","article-title":"Gut microbiota alterations and outcomes in severe acute pancreatitis: insights from metagenomic profiling","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.pan.2025.11.012_bib4","first-page":"112","article-title":"Microbiota-targeted interventions in acute pancreatitis: time for translational studies","volume":"21","author":"De-Madaria","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2025.11.012_bib5","first-page":"795","article-title":"Antibiotic prophylaxis in necrotizing pancreatitis: reappraising old dogmas","volume":"8","author":"Boxhoorn","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325006854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325006854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T20:49:21Z","timestamp":1777754961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390325006854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1424390325006854"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2025.11.012","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluating rifaximin prophylaxis in severe acute pancreatitis: A call for methodological refinement and microbiome-centric endpoints","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2025.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}